Michael Greig, Dir. Pharma/Biopharma Americas, Bruker Daltonics discusses CCS and Benefits of TIMS



January 26, 2021

Become CCS-Aware! The benefits of Trapped Ion Mobility Spectrometry (TIMS) and Collisional Cross Section (CCS) for Molecular Characterization in Drug Discovery and Development. Bruker’s timsTOF platforms measure ion mobilities using first principles for all analytes, assigning collisional cross section (CCS) values for small molecules, metabolites, lipids, peptides, and proteins. Experiments are enhanced with the 4th dimensional CCS value - improving the fidelity of protein and peptide assignments, more accurate quantification and isotope matching with improved S/N, deciphered isomeric species, as well as many CCS predictive tools to assist in molecular confirmation and unknown ID.

Analytical TechniquesBiopharmaMass Spectrometry

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.